Literature DB >> 9876806

Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group.

S A Spinler1, J J Nawarskas, E G Boyce, J E Connors, S L Charland, S Goldfarb.   

Abstract

OBJECTIVE: The predictive performance of 10 equations used to estimate creatinine clearance (Clcr) was assessed retrospectively from data collected on 420 patients.
DESIGN: This study is a retrospective data analysis of information collected on hemodynamically stable patients awaiting coronary angiography during the Iohexol Cooperative Study.
SETTING: The Iohexol Cooperative Study was a multicenter study that compared nephrotoxicity of high- and low-osmolar contrast media in patients undergoing coronary angiography. Data used for this analysis were preangiography 24-hour urine collections that were primarily collected in hospitalized patients. PATIENTS: Patients selected from the Iohexol Cooperative Study database for analysis were participants categorized into one or more of six subgroups: elderly (n = 222), hypoalbuminemic (n = 25), chronic renal insufficiency (n = 128), low serum creatinine (n = 115), obese (n = 208), and diabetic (n = 191) who had baseline urine collections of at least 24 hours. OUTCOME MEASURES: Predictive performance was assessed using bias, precision, slopes, and y-intercepts.
RESULTS: The Salazar-Corcoran equation was unbiased in the entire group as well as in five of the subgroups. The Cockcroft-Gault equation was unbiased in three of the subgroups. All other equations were biased in predicting Clcr in the entire group as well as in at least four of the subgroups. Precision was generally poor. All slopes were significantly different than one and all y-intercepts were significantly different than zero (p < 0.01). Correlation coefficients were between 0.63 and 0.79 with the exceptions of the low serum creatinine subgroup (r values 0.35-0.64) and the Davis-Chandler equation (r values 0.35-0.71 across groups).
CONCLUSIONS: Of the equations studied, Salazar-Corcoran and Cockcroft-Gault appear to be the best for predicting Clcr.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9876806     DOI: 10.1345/aph.18122

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  21 in total

1.  Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures.

Authors:  Rick A Kuntz; David W Holt; Scott Turner; Lee Stichka; Bryan Thacker
Journal:  J Extra Corpor Technol       Date:  2006-06

2.  Effect of diltiazem on kidney function during laparoscopic surgery.

Authors:  Ji Young Kim; Kyung Cheon Lee; Hong Soon Kim; Youn Yi Jo; Hyun Jeong Kwak
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

3.  New standardized cystatin C and creatinine GFR equations in children validated with inulin clearance.

Authors:  Ulla B Berg; Ulf Nyman; Rune Bäck; Magnus Hansson; Kajsa Åsling Monemi; Maria Herthelius; Jonas Björk
Journal:  Pediatr Nephrol       Date:  2015-04-23       Impact factor: 3.714

4.  Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults.

Authors:  Aaron M Cook; Craig Martin; Val R Adams; R Scott Morehead
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

5.  Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients.

Authors:  João Pedro Baptista; Marta Neves; Luis Rodrigues; Luísa Teixeira; João Pinho; Jorge Pimentel
Journal:  J Nephrol       Date:  2014-01-21       Impact factor: 3.902

6.  Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.

Authors:  Grégoire Wuerzner; Murielle Bochud; Vittorio Giusti; Michel Burnier
Journal:  Obes Facts       Date:  2011-06-06       Impact factor: 3.942

Review 7.  Kidney Function in Obesity-Challenges in Indexing and Estimation.

Authors:  Alex R Chang; Waleed Zafar; Morgan E Grams
Journal:  Adv Chronic Kidney Dis       Date:  2018-01       Impact factor: 3.620

8.  Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer.

Authors:  Bercin Kutluk Cenik; Han Sun; David E Gerber
Journal:  Lung Cancer       Date:  2013-03-15       Impact factor: 5.705

9.  Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations.

Authors:  Lesley A Stevens; Thomas D Nolin; Michelle M Richardson; Harold I Feldman; Julia B Lewis; Roger Rodby; Raymond Townsend; Aghogho Okparavero; Yaping Lucy Zhang; Christopher H Schmid; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2009-05-17       Impact factor: 8.860

10.  Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis.

Authors:  Eugenia Raichlin; Abhiram Prasad; Verghese Mathew; Bailey Kent; David R Holmes; Geralyn M Pumper; Rebecca E Nelson; Lilach O Lerman; Amir Lerman
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.